Brokerages Set InterContinental Hotels Group PLC (IHG) Price Target at $66.00

Share on StockTwits

InterContinental Hotels Group PLC (NYSE:IHG) has earned a consensus rating of “Hold” from the eight ratings firms that are presently covering the firm, Marketbeat reports. One research analyst has rated the stock with a sell recommendation, five have given a hold recommendation and two have issued a buy recommendation on the company. The average 1 year price objective among analysts that have covered the stock in the last year is $66.00.

A number of brokerages recently commented on IHG. Zacks Investment Research upgraded InterContinental Hotels Group from a “hold” rating to a “buy” rating and set a $72.00 target price for the company in a research note on Thursday, May 3rd. ValuEngine lowered InterContinental Hotels Group from a “buy” rating to a “hold” rating in a research note on Saturday, June 2nd. Bank of America lowered InterContinental Hotels Group from a “buy” rating to a “neutral” rating in a research note on Friday, May 11th. Finally, SunTrust Banks upped their target price on InterContinental Hotels Group to $66.00 and gave the company a “hold” rating in a research note on Tuesday, February 27th.

Institutional investors have recently added to or reduced their stakes in the business. Financial Gravity Companies Inc. acquired a new position in InterContinental Hotels Group during the fourth quarter worth $143,000. UBS Group AG raised its stake in InterContinental Hotels Group by 238.8% during the first quarter. UBS Group AG now owns 2,175 shares of the company’s stock worth $133,000 after acquiring an additional 1,533 shares in the last quarter. Financial Gravity Wealth Inc. acquired a new position in InterContinental Hotels Group during the first quarter worth $159,000. Ladenburg Thalmann Financial Services Inc. raised its stake in InterContinental Hotels Group by 133.7% during the first quarter. Ladenburg Thalmann Financial Services Inc. now owns 2,625 shares of the company’s stock worth $161,000 after acquiring an additional 1,502 shares in the last quarter. Finally, US Bancorp DE raised its stake in InterContinental Hotels Group by 30.9% during the fourth quarter. US Bancorp DE now owns 3,332 shares of the company’s stock worth $212,000 after acquiring an additional 786 shares in the last quarter. Hedge funds and other institutional investors own 6.38% of the company’s stock.

Shares of NYSE IHG traded up $0.16 during trading hours on Friday, reaching $66.55. The stock had a trading volume of 67,900 shares, compared to its average volume of 281,119. The company has a current ratio of 0.64, a quick ratio of 0.64 and a debt-to-equity ratio of -2.22. The firm has a market capitalization of $12.74 billion, a price-to-earnings ratio of 27.39, a PEG ratio of 2.46 and a beta of 1.32. InterContinental Hotels Group has a twelve month low of $49.03 and a twelve month high of $69.23.

InterContinental Hotels Group Company Profile

InterContinental Hotels Group PLC owns, manages, franchises, and leases hotels in the Americas, Europe, Asia, the Middle East, Africa, and Greater China. The company operates hotels, resorts, and restaurants under the InterContinental, Kimpton, Hotel Indigo, EVEN, HUALUXE, Crowne Plaza, Holiday Inn, Holiday Inn Express, Holiday Inn Club Vacations, Holiday Inn Resort, avid, Staybridge Suites, and Candlewood Suites brands.

Analyst Recommendations for InterContinental Hotels Group (NYSE:IHG)

Receive News & Ratings for InterContinental Hotels Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InterContinental Hotels Group and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Axiom Price Reaches $0.0078 on Exchanges
Axiom Price Reaches $0.0078 on Exchanges
Starta Hits 24-Hour Trading Volume of $0.00
Starta Hits 24-Hour Trading Volume of $0.00
Zacks: Brokerages Expect MTS Systems Co.  Will Announce Earnings of $0.63 Per Share
Zacks: Brokerages Expect MTS Systems Co. Will Announce Earnings of $0.63 Per Share
Obalon Therapeutics  Getting Somewhat Positive Media Coverage, Study Shows
Obalon Therapeutics Getting Somewhat Positive Media Coverage, Study Shows
Novus Therapeutics  Receives News Impact Score of 0.16
Novus Therapeutics Receives News Impact Score of 0.16
$4.68 Earnings Per Share Expected for Regeneron Pharmaceuticals Inc  This Quarter
$4.68 Earnings Per Share Expected for Regeneron Pharmaceuticals Inc This Quarter


Leave a Reply

 
© 2006-2018 Zolmax.